MC

461.1

-1.52%↓

SANES

6.85

-2.09%↓

BNP

75.13

-1.82%↓

ALV

341.4

-0.47%↓

BBVA

12.935

-2.12%↓

MC

461.1

-1.52%↓

SANES

6.85

-2.09%↓

BNP

75.13

-1.82%↓

ALV

341.4

-0.47%↓

BBVA

12.935

-2.12%↓

MC

461.1

-1.52%↓

SANES

6.85

-2.09%↓

BNP

75.13

-1.82%↓

ALV

341.4

-0.47%↓

BBVA

12.935

-2.12%↓

MC

461.1

-1.52%↓

SANES

6.85

-2.09%↓

BNP

75.13

-1.82%↓

ALV

341.4

-0.47%↓

BBVA

12.935

-2.12%↓

MC

461.1

-1.52%↓

SANES

6.85

-2.09%↓

BNP

75.13

-1.82%↓

ALV

341.4

-0.47%↓

BBVA

12.935

-2.12%↓

Search

AB Science SA

Chiusa

1.17 1.04

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.17

Massimo

1.17

Metriche Chiave

By Trading Economics

Entrata

-4.5M

Vendite

560K

Margine di Profitto

-798.036

Dipendenti

28

EBITDA

-4.6M

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

78M

Apertura precedente

0.13

Chiusura precedente

1.17

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

AB Science SA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 giu 2025, 22:33 UTC

Acquisizioni, Fusioni, Takeovers

Millicom to Acquire Telefonica Ecuador for $380 Million

14 giu 2025, 01:24 UTC

Acquisizioni, Fusioni, Takeovers

Nippon to Close U.S. Steel Deal After National-Security Pact With Trump -- 3rd Update

13 giu 2025, 23:50 UTC

Acquisizioni, Fusioni, Takeovers

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- 2nd Update

13 giu 2025, 23:20 UTC

Acquisizioni, Fusioni, Takeovers

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- Update

13 giu 2025, 23:09 UTC

Acquisizioni, Fusioni, Takeovers

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- WSJ

13 giu 2025, 23:03 UTC

Acquisizioni, Fusioni, Takeovers

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal --WSJ

13 giu 2025, 22:18 UTC

Acquisizioni, Fusioni, Takeovers

Millicom to Acquire Telefonica Ecuador for $380M

13 giu 2025, 22:04 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Better Data Facilitate Investments In Oil Patch -- Market Talk

13 giu 2025, 21:42 UTC

Acquisizioni, Fusioni, Takeovers

Anne Wojcicki Wins Bidding for 23andMe -- 2nd Update

13 giu 2025, 21:35 UTC

Acquisizioni, Fusioni, Takeovers

Bunge: Outside Date Extended to July 3

13 giu 2025, 21:35 UTC

Acquisizioni, Fusioni, Takeovers

Bunge: Subject to Satisfaction of Remaining Conditions, Bunge and Sellers Expect to Complete Transaction July 2

13 giu 2025, 21:34 UTC

Acquisizioni, Fusioni, Takeovers

Bunge Gets Mexico Approval for Viterra Deal

13 giu 2025, 21:32 UTC

Acquisizioni, Fusioni, Takeovers

Bunge Gets China Approval for Viterra Deal

13 giu 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

13 giu 2025, 20:45 UTC

Acquisizioni, Fusioni, Takeovers

23andMe: TTAM Makes Binding Commitments for Additional Consumer Protections and Privacy Safeguards

13 giu 2025, 20:34 UTC

Acquisizioni, Fusioni, Takeovers

Anne Wojcicki Wins Bidding for 23andMe -- Update

13 giu 2025, 20:14 UTC

Acquisizioni, Fusioni, Takeovers

Nonprofit Controlled By 23andMe Co-Founder Anne Wojcicki Would Buy the DNA-Testing Company for $305 Million -- WSJ

13 giu 2025, 20:14 UTC

Acquisizioni, Fusioni, Takeovers

Anne Wojcicki Wins Bidding for 23andMe -- WSJ

13 giu 2025, 20:14 UTC

Acquisizioni, Fusioni, Takeovers

Regeneron Walks Away From 23andMe Acquisition After Wojcicki's Higher Bid -- WSJ

13 giu 2025, 19:30 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

13 giu 2025, 19:12 UTC

Discorsi di Mercato

Oil Futures Jump As Israel Strikes Iranian Targets -- Market Talk

13 giu 2025, 19:04 UTC

Discorsi di Mercato

Canada Military Spending Hike to Lift Long-Term Yields -- Market Talk

13 giu 2025, 18:54 UTC

Discorsi di Mercato

Correction to Gold Settles Market Talk

13 giu 2025, 18:01 UTC

Discorsi di Mercato

Gold Settles at Record High -- Market Talk

13 giu 2025, 17:40 UTC

Discorsi di Mercato

U.S. Oil Rig Count Falls By 3 to 439 -- Market Talk

13 giu 2025, 17:21 UTC

Discorsi di Mercato

Dollar Index, Commodities Rise -- Market Talk

13 giu 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

Advent Proposal Values Spectris at GBP37.63 Per Share, Company Said Monday -- WSJ

13 giu 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

KKR Is Preparing a Bid for High-Tech Instrument Maker Spectris, Sources Say -- WSJ

13 giu 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

Private-Equity Firm Is Vying With Advent for the U.K. Company, Sources Say -- WSJ

13 giu 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

KKR Making Competing Bid for Equipment Maker Spectris -- WSJ

Confronto tra pari

Modifica del prezzo

AB Science SA Previsione

Punteggio Tecnico

By Trading Central

1.426 / 1.448Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Bullish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.